LU91133I9 - Novel quinuclidine derivatives and medicinal composition thereof - Google Patents

Novel quinuclidine derivatives and medicinal composition thereof

Info

Publication number
LU91133I9
LU91133I9 LU91133C LU91133C LU91133I9 LU 91133 I9 LU91133 I9 LU 91133I9 LU 91133 C LU91133 C LU 91133C LU 91133 C LU91133 C LU 91133C LU 91133 I9 LU91133 I9 LU 91133I9
Authority
LU
Luxembourg
Prior art keywords
quinuclidine derivatives
medicinal composition
diseases
novel quinuclidine
novel
Prior art date
Application number
LU91133C
Other languages
English (en)
Other versions
LU91133I2 (fr
Inventor
Yasuo Isomura
Makoto Takeuchi
Ryo Naito
Masahiko Hayakawa
Yoshinori Okamoto
Yasuhiro Yonetoku
Ken Ikeda
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18194699&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU91133(I9) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of LU91133I2 publication Critical patent/LU91133I2/fr
Publication of LU91133I9 publication Critical patent/LU91133I9/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C07D221/12—Phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00—Liquid crystal materials
    • C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06—Non-steroidal liquid crystal compounds
    • C09K19/34—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3441—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom
    • C09K19/3444—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom the heterocyclic ring being a six-membered aromatic ring containing one nitrogen atom, e.g. pyridine
LU91133C 1994-12-28 2005-01-28 Novel quinuclidine derivatives and medicinal composition thereof LU91133I9 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP32704594 1994-12-28
PCT/JP1995/002713 WO1996020194A1 (fr) 1994-12-28 1995-12-27 Nouveaux derives de quinuclidine et composition pharmaceutique les contenant

Publications (2)

Publication Number Publication Date
LU91133I2 LU91133I2 (fr) 2005-03-29
LU91133I9 true LU91133I9 (en) 2018-08-01

Family

ID=18194699

Family Applications (1)

Application Number Title Priority Date Filing Date
LU91133C LU91133I9 (en) 1994-12-28 2005-01-28 Novel quinuclidine derivatives and medicinal composition thereof

Country Status (24)

Country Link
US (2) US6017927A (fr)
EP (1) EP0801067B1 (fr)
JP (1) JP3014457B2 (fr)
KR (1) KR100386487B1 (fr)
CN (1) CN1045601C (fr)
AT (1) ATE233761T1 (fr)
AU (1) AU695616B2 (fr)
CA (1) CA2208839C (fr)
DE (2) DE122004000048I2 (fr)
DK (1) DK0801067T3 (fr)
ES (1) ES2193208T3 (fr)
FI (1) FI115631B (fr)
FR (1) FR04C0032I2 (fr)
HU (1) HU223778B1 (fr)
LU (1) LU91133I9 (fr)
MX (1) MX9704880A (fr)
NL (1) NL300141I2 (fr)
NO (4) NO2005012I1 (fr)
NZ (1) NZ298144A (fr)
PL (1) PL182344B1 (fr)
PT (1) PT801067E (fr)
RU (1) RU2143432C1 (fr)
TW (1) TW305842B (fr)
WO (1) WO1996020194A1 (fr)

Families Citing this family (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008128028A2 (fr) * 2007-04-11 2008-10-23 Dr. Reddy's Laboratories Ltd. Compositions à base de solifénacine
US20100137358A1 (en) * 1996-11-05 2010-06-03 Dr. Reddy's Laboratories Ltd. Solifenacin compositions
FR2772378B1 (fr) * 1997-12-12 2000-02-04 Synthelabo Derives d'imidazole, leur preparation et leur application en therapeutique
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US7214687B2 (en) 1999-07-14 2007-05-08 Almirall Ag Quinuclidine derivatives and medicinal compositions containing the same
JP2001316670A (ja) * 2000-05-02 2001-11-16 Dainippon Ink & Chem Inc 液晶組成物
US6916828B2 (en) * 2000-06-27 2005-07-12 Laboratorios S.A.L.V.A.T., S.A. Carbamates derivatived from arylakylamines
PL362989A1 (en) * 2000-12-22 2004-11-15 Almirall Prodesfarma Ag Quinuclidine carbamate derivatives and their use as m3 antagonists
SK287414B6 (sk) 2000-12-28 2010-09-07 Laboratorios Almirall, S.A. Chinuklidínové deriváty a kompozície s ich obsahom
EP1405638B1 (fr) * 2001-07-10 2011-02-09 Astellas Pharma Inc. Composition pharmaceutique comprenant de la quinuclidin-3'-yl 1-phenyl-1,2,3,4,-tetrahydroisoquinoline-2-carboxylate pour le traitement de la cystite interstitielle et/ou de la prostatite non-bactérienne
HUP0500107A3 (en) * 2001-12-20 2011-05-30 Chiesi Farma Spa 1-alkyl-1-azoniabicyclo[2.2.2.]octane carbamate derivatives, pharmaceutical compositions comprising thereof and their use as muscarinic receptor antagonists
EP1552825A4 (fr) * 2002-06-07 2009-11-25 Astellas Pharma Inc Agent therapeutique pour le traitement de l'hyperactivite vesicale
ES2203327B1 (es) 2002-06-21 2005-06-16 Almirall Prodesfarma, S.A. Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
ES2204295B1 (es) 2002-07-02 2005-08-01 Almirall Prodesfarma, S.A. Nuevos derivados de quinuclidina-amida.
DE60230683D1 (de) 2002-07-08 2009-02-12 Ranbaxy Lab Ltd 3,6-disubstituierte azabicyclo-3.1.0 hexan-derivat
WO2004014853A1 (fr) 2002-07-31 2004-02-19 Ranbaxy Laboratories Limited Derives 3,6-disubstitues d'azabicyclo [3.1.0]hexane utilises comme antagonistes des recepteurs muscariniques
WO2004014363A1 (fr) 2002-08-09 2004-02-19 Ranbaxy Laboratories Limited Derives d'azabicyclo[3.1.0] hexane 3,6-disubstitues, utiles en tant qu'agonistes de recepteurs muscariniques
DE60231341D1 (de) 2002-08-23 2009-04-09 Ranbaxy Lab Ltd Fluor- und sulfonylaminohaltige, 3,6-disubstituierptorantagonisten
MXPA05003398A (es) * 2002-10-29 2005-06-22 Pharmacia & Upjohn Co Llc Compuestos de amonio cuaternario.
JP2006518707A (ja) 2002-12-10 2006-08-17 ランバクシー ラボラトリーズ リミテッド ムスカリン様受容体アンタゴニストとしての３，６−二置換アザビシクロ［３．１．０］ヘキサン誘導体
PL376949A1 (pl) * 2002-12-20 2006-01-09 Dynogen Pharmaceuticals, Inc. Sposoby leczenia niebolesnych zaburzeń pęcherza moczowego przy użyciu modulatorów podjednostki Ó2Ű kanału wapniowego
EP1583741A1 (fr) 2002-12-23 2005-10-12 Ranbaxy Laboratories, Limited Derives de 1-substitues-3-pyrrolidines comme antagonistes de recepteurs muscariniques
AU2002347553A1 (en) 2002-12-23 2004-07-14 Ranbaxy Laboratories Limited Flavaxate derivatives as muscarinic receptor antagonists
US7488748B2 (en) 2003-01-28 2009-02-10 Ranbaxy Laboratories Limited 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
CN1791399A (zh) * 2003-03-21 2006-06-21 戴诺根医药品公司 用α2δ亚基钙通道调节剂和平滑肌调节剂一起治疗下泌尿道病症的方法
WO2004089898A1 (fr) 2003-04-09 2004-10-21 Ranbaxy Laboratories Limited Derives d'azabicyclo hexane substitues en tant qu'antagonistes de recepteurs muscariniques
US7560479B2 (en) 2003-04-10 2009-07-14 Ranbaxy Laboratories Limited 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
EP1615634B1 (fr) 2003-04-10 2007-05-16 Ranbaxy Laboratories, Ltd. Derives d'azabicyclo hexane en tant qu'antagonistes des recepteurs muscariniques
BRPI0409302A (pt) 2003-04-11 2006-04-11 Ranbaxy Lab Ltd derivados azabiciclo como antagonistas de recetores muscarìnicos, método para sua preparação e composição farmacêutica contendo os mesmos
WO2004091597A2 (fr) * 2003-04-15 2004-10-28 Pharmacia & Upjohn Company Llc Procede pour traiter le syndrome du colon irritable
US20050175689A1 (en) * 2003-10-27 2005-08-11 Yamanouchi Pharmaceutical Co., Ltd. Coated fine particles containing drug for intrabuccally fast disintegrating tablet
EP1714965A4 (fr) * 2004-02-09 2007-12-19 Astellas Pharma Inc Composition contenant du succinate de solifenacine
WO2005077364A1 (fr) * 2004-02-18 2005-08-25 Yamanouchi Pharmaceutical Co., Ltd. Préparation transdermique de solifénacine et procédé d'amélioration de la perméabilité transdermique de celle-ci
WO2005087231A1 (fr) * 2004-03-16 2005-09-22 Astellas Pharma Inc. Composition contenant de la solifenacine
JPWO2005087231A1 (ja) * 2004-03-16 2008-01-24 アステラス製薬株式会社 ソリフェナシン含有組成物
EP1728791A4 (fr) * 2004-03-25 2008-12-10 Astellas Pharma Inc Composition pour la preparation pharmaceutique solide de solifenacine ou des sels de cette derniere
ZA200608614B (en) * 2004-03-25 2008-06-25 Astellas Pharma Inc Composition for solid pharmaceutical preparation of solifenacin or salt thereof
WO2006035280A1 (fr) * 2004-09-27 2006-04-06 Ranbaxy Laboratories Limited Antagonistes des recepteurs muscariniques
US20090105221A1 (en) * 2004-09-29 2009-04-23 Ranbaxy Laboratories Limited Muscarinic receptor antagonists
BRPI0519270A2 (pt) * 2004-12-27 2009-01-06 Astellas Pharma Inc composiÇço farmacÊutica particulada estÁvel de solifenacina ou um sal
WO2006070735A1 (fr) * 2004-12-27 2006-07-06 Astellas Pharma Inc. Préparation pharmaceutique granulaire stable de solifénacine ou de son sel
US20090131469A1 (en) * 2005-02-25 2009-05-21 Astellas Pharma Inc. Pharmaceutical agent comprising solifenacin
JP3701964B1 (ja) * 2005-03-08 2005-10-05 アステラス製薬株式会社 キヌクリジン誘導体の新規な塩
WO2007007281A2 (fr) * 2005-07-11 2007-01-18 Ranbaxy Laboratories Limited Antagonistes des recepteurs muscariniques
US7815939B2 (en) 2005-07-20 2010-10-19 Astellas Pharma Inc. Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms
US20090221664A1 (en) 2005-10-19 2009-09-03 Abhijit Ray Pharmaceutical compositions of muscarinic receptor antagonists
CA2630846A1 (fr) * 2005-12-21 2007-07-05 Teva Pharmaceutical Industries Ltd. Procedes de preparation de solifenacine
CZ300699B6 (cs) 2006-06-21 2009-07-22 Zentiva, A. S. Zpusob prípravy solifenacinu
WO2008011462A2 (fr) * 2006-07-19 2008-01-24 Dr. Reddy's Laboratories Ltd. Procédé de fabrication de solifénacine et de ses sels
ES2298049B1 (es) 2006-07-21 2009-10-20 Laboratorios Almirall S.A. Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
WO2008013851A2 (fr) * 2006-07-24 2008-01-31 Teva Pharmaceutical Industries Ltd. Procédés de préparation de forme polymorphes de succinate de solifénacine
WO2008019103A2 (fr) * 2006-08-03 2008-02-14 Teva Pharmaceutical Industries Ltd Formes de solifénacine base et leur préparation
TW200825084A (en) * 2006-11-14 2008-06-16 Astrazeneca Ab New compounds 521
EP2102200A2 (fr) * 2006-11-22 2009-09-23 Medichem, S.A. Procédé perfectionné pour la synthèse de solifénacine
CZ300692B6 (cs) * 2006-12-22 2009-07-15 Zentiva, A. S. Zpusob prípravy solifenacinu
CN101711248A (zh) * 2007-03-30 2010-05-19 医药化学公司 一种改进的素非那新合成工艺
US20090099365A1 (en) * 2007-07-13 2009-04-16 Nurit Perlman Processes for solifenacin preparation
EP2172201A4 (fr) * 2007-07-20 2011-07-06 Astellas Pharma Inc Composition pharmaceutique pour une amélioration du symptôme des voies urinaires inférieures associé à une prostatomégalie
EP2018850A1 (fr) * 2007-07-24 2009-01-28 Ratiopharm GmbH Composition pharmaceutique comportant de la solifénacine ou sel acceptable pharmaceutiquement
SI2216021T1 (sl) * 2007-11-02 2013-01-31 Astellas Pharma Inc. Farmacevtski sestavek za zdravljenje prekomerno aktivnega sečnega mehurja
EP2484681A1 (fr) 2007-12-04 2012-08-08 Cadila Healthcare Limited Sel de gentisate pur chimiquement et chiralement de solifénacine
US8476297B2 (en) 2007-12-04 2013-07-02 Amgen Inc. TRP-M8 receptor ligands and their use in treatments
ITMI20080195A1 (it) 2008-02-08 2009-08-09 Dipharma Francis Srl Procedimento per la preparazione di solifenacin
EP2100599A1 (fr) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Composition à inhaler comprenant aclidinium pour le traitement de l'asthme et de maladies respiratoires obstructives chroniques
EP2100598A1 (fr) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Composition à inhaler comprenant aclidinium pour le traitement de l'asthme et de maladies respiratoires obstructives chroniques
US8404701B2 (en) 2008-03-27 2013-03-26 Chase Pharmaceuticals Corporation Use and composition for treating dementia
PL385264A1 (pl) 2008-05-23 2009-12-07 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Sposób wytwarzania enancjomerycznie czystej (S)-1-fenylo-1, 2, 3, 4-tetrahydroizochinoliny
PL385265A1 (pl) 2008-05-23 2009-12-07 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Sposób wytwarzania solifenacyny i/lub jej soli o wysokiej czystości farmaceutycznej
EP2310387A2 (fr) 2008-07-29 2011-04-20 KRKA, D.D., Novo Mesto Procede de preparation de sels de solifenacin et d' utilisation de ceux-ci aux compositions pharmaceutiques
EP2181707A1 (fr) 2008-11-04 2010-05-05 Astellas Ireland Co., Ltd. Utilisation combinée d'un antagoniste de récepteur alpha-adrénergique et d'un agent anti-muscarinique
JP5553026B2 (ja) 2009-02-04 2014-07-16 アステラス製薬株式会社 経口投与用医薬組成物
PL2406257T3 (pl) 2009-03-09 2020-01-31 Megafine Pharma (P) Ltd. Nowy sposób wytwarzania solifenacyny i jej nowy produkt pośredni
WO2010113840A1 (fr) 2009-03-30 2010-10-07 アステラス製薬株式会社 Composition pharmaceutique solide contenant un corps amorphe de solifénacine
WO2011048607A1 (fr) 2009-09-25 2011-04-28 Cadila Healthcare Limited Procédés de préparation de solifénacine ou d'un de ses sels
PL234208B1 (pl) 2010-01-18 2020-01-31 Zakl Farmaceutyczne Polpharma Spolka Akcyjna Sposób wytwarzania bursztynianu solifenacyny
ES2604705T3 (es) 2010-03-31 2017-03-08 Ono Pharmaceutical Co., Ltd. Agente preventivo y/o remedio para el síndrome mano-pie
US8748433B2 (en) 2010-04-30 2014-06-10 Merck Sharp & Dohme Corp. β3 adrenergic receptor agonists
CA2799942C (fr) 2010-05-19 2018-07-17 Astellas Pharma Inc. Composition pharmaceutique contenant de la solifenacine
US8772491B2 (en) 2010-06-28 2014-07-08 Aurobindo Pharma Ltd Process for the preparation of solifenacin succinate
EP2590973B1 (fr) 2010-07-05 2016-08-31 Crystal Pharma, S.A.U. Sels de solifenacine
CA2817336A1 (fr) 2010-11-11 2012-05-18 Hexal Ag Succinate de solifenacine cristallin
EP2510928A1 (fr) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium pour l'amélioration du sommeil des patients avec des maldadies respiratoires
MX348723B (es) 2011-05-10 2017-06-27 Theravida Inc Combinaciones de solifenacina y estimulantes salivales para el tratamiento de la vejiga hiperactiva.
US20140228575A1 (en) 2011-06-22 2014-08-14 Isochem Process for the Preparation of Solifenacin and Salts Thereof
KR101365849B1 (ko) 2012-03-28 2014-02-24 경동제약 주식회사 솔리페나신 또는 그의 염의 제조방법 및 이에 사용되는 신규 중간체
EP2867210A1 (fr) 2012-07-02 2015-05-06 Pharmathen S.A. Procédé pour la préparation de solifénacine ou d'un de ses sels
WO2014034860A1 (fr) 2012-08-31 2014-03-06 アステラス製薬株式会社 Composition médicale administrée par voie orale
EA038489B1 (ru) 2012-09-05 2021-09-06 Чейс Фамасьютикалз Корпорейшн Антихолинэргическая нейропротективная композиция и способы
CN103787969B (zh) 2012-10-30 2016-07-06 上海京新生物医药有限公司 一种(1s)-1-苯基-3,4-二氢-2（1h）-异喹啉甲酸酯的制备方法
RU2661877C2 (ru) * 2012-12-06 2018-07-20 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Соединения, обладающие активностью антагонистов мускариновых рецепторов и агонистов бета-2-адренергических рецепторов
EP2778167A1 (fr) 2013-03-11 2014-09-17 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Composition pharmaceutique comprenant solifenacin ou l'un de ses sels pharmaceutiquement acceptable
WO2015007073A1 (fr) * 2013-07-13 2015-01-22 北京市丰硕维康技术开发有限责任公司 Composés à base de quinine, et isomères optiques, procédé de préparation et utilisation médicale associes
US20170065589A1 (en) 2014-05-06 2017-03-09 Anthony G. Visco Methods of treating or preventing preterm labor
CN104592221A (zh) * 2015-01-26 2015-05-06 中山奕安泰医药科技有限公司 一种合成索非那新的工艺
KR20160146428A (ko) 2015-06-12 2016-12-21 한미정밀화학주식회사 솔리페나신 또는 그의 약학적으로 허용되는 염과 락토즈를 포함하는 안정한 무정형 솔리페나신 약학 조성물 및 그의 제조방법
KR102148414B1 (ko) 2017-05-15 2020-08-26 주식회사 서울제약 솔리페나신을 유효성분으로 하는 구강붕해필름
US20210163471A1 (en) 2017-12-12 2021-06-03 Arkuda Therapeutics Progranulin modulators and methods of using the same
MX2021014484A (es) * 2019-06-12 2022-01-06 Arkuda Therapeutics Moduladores de la progranulina y metodos de uso de estos.
CN113200979A (zh) * 2021-04-13 2021-08-03 上海予君生物科技发展有限公司 一种琥珀酸索非那新的合成工艺

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0247266B1 (fr) * 1986-01-07 1993-03-10 Beecham Group Plc Dérivés d'indole ayant une chaîne latérale azabicyclique, procédé pour leur préparation, produits intermédiaires et compositions pharmaceutiques
IT1231238B (it) * 1987-09-21 1991-11-26 Angeli Inst Spa Derivati ammidinici
GB9023023D0 (en) * 1990-10-23 1990-12-05 Barlow Richard B Pharmaceutical compositions
GB9202443D0 (en) * 1992-02-05 1992-03-18 Fujisawa Pharmaceutical Co A novel substituted-acetamide compound and a process for the preparation thereof
JPH076635A (ja) * 1993-06-18 1995-01-10 Sony Corp 信号伝送ケーブル
AU7545894A (en) * 1993-09-02 1995-03-22 Yamanouchi Pharmaceutical Co., Ltd. Carbamate derivative and medicine containing the same
JPH07258250A (ja) * 1994-03-25 1995-10-09 Yamanouchi Pharmaceut Co Ltd エステル誘導体
ATE339121T1 (de) * 2002-11-27 2006-10-15 Selmac S R L Vorrichtung zum positionieren und spannen geformter teile und damit ausgerüstete maschine

Also Published As

Publication number Publication date
NO2017055I1 (no) 2017-11-06
EP0801067A1 (fr) 1997-10-15
AU695616B2 (en) 1998-08-20
AU4355396A (en) 1996-07-19
NO2005012I1 (no) 2005-06-06
CA2208839C (fr) 2006-01-31
FR04C0032I2 (fr) 2005-10-21
EP0801067B1 (fr) 2003-03-05
CN1045601C (zh) 1999-10-13
DE122004000048I2 (de) 2006-02-02
FI972775A (fi) 1997-08-22
NO2017055I2 (no) 2017-11-06
PL321019A1 (en) 1997-11-24
FR04C0032I1 (fr) 2005-02-11
DE69529844D1 (de) 2003-04-10
US6017927A (en) 2000-01-25
KR100386487B1 (ko) 2003-09-26
DK0801067T3 (da) 2003-06-30
JPH09508401A (ja) 1997-08-26
KR987000303A (ko) 1998-03-30
DE69529844T2 (de) 2004-03-04
FI972775A0 (fi) 1997-06-27
US6174896B1 (en) 2001-01-16
FI115631B (fi) 2005-06-15
HUT77006A (hu) 1998-03-02
TW305842B (fr) 1997-05-21
CN1171109A (zh) 1998-01-21
ATE233761T1 (de) 2003-03-15
HU223778B1 (hu) 2005-01-28
NO973027L (no) 1997-08-28
NO318026B1 (no) 2005-01-24
CA2208839A1 (fr) 1996-07-04
NL300141I1 (nl) 2004-04-01
MX9704880A (es) 1997-10-31
NZ298144A (en) 1998-04-27
PT801067E (pt) 2003-07-31
NO2005016I2 (no) 2008-02-11
EP0801067A4 (fr) 1998-03-11
LU91133I2 (fr) 2005-03-29
NL300141I2 (nl) 2004-04-01
NO2005016I1 (no) 2005-08-29
NO973027D0 (no) 1997-06-27
PL182344B1 (pl) 2001-12-31
WO1996020194A1 (fr) 1996-07-04
ES2193208T3 (es) 2003-11-01
DE122004000048I1 (de) 2005-04-21
JP3014457B2 (ja) 2000-02-28
RU2143432C1 (ru) 1999-12-27

Similar Documents

Publication Publication Date Title
LU91133I9 (en) Novel quinuclidine derivatives and medicinal composition thereof
NO942953D0 (no) 11-benzaldoksimestradienderivater, fremgangsmåte for deres fremstilling smat legemddel inneholdende slike
AU673893B2 (en) New pyridothiadiazones, processes for their preparation and the pharmaceutical compositions which contain them
ATE109484T1 (de) Thienopyridin -derivative und diese enthaltende arzneimittel.
HUT59139A (en) Process for producing tricyclic compounds and antimicrobial pharmaceutical compositions comprising same
EP1329218A4 (fr) Agents preventifs/remedes destines a l'hypertension portale
ZA921341B (en) 4-((2-benzothiazolyl)methylamino)-a-(3,4-difluorophenoxy) methyl)-1-piperidineethanol.
AU3559793A (en) New 3-aminochroman spiro compounds, processes for their preparation and pharmaceutical compositions containing them
NO910904D0 (no) Fremgangsmaate for fremstilling av en substituert aminforbindelse.
HU9401159D0 (en) New compound leustroducsin h, its preparation and pharmaceutical compositions containing them